Sign In
test

Weston Nichols

Lynx1 Capital Management Lp

Assets Managed
$632.718M
Holdings
23
Last Quarter
2026 - Q1
Filed Date
4d ago
Growth Rate
28.09%(2Q avg: 14.32%)
Sustained Growth
5 quarters

Portfolio positions

This chart displays the top 10 holdings in Lynx1 Capital Management Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 23 positions.

Assets under management

The assets under management (AUM) of Lynx1 Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 5 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 632.718M in assets, with a quarterly growth rate of 28.09% and a 2-quarter average growth rate of 14.32%. The portfolio is managed by Weston Nichols, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
STOK
Stoke Therapeutics Inc
Recent Activity
Decreased -11.86%
24.52%
$155.105M
4.764M shares@ $32.57 avg price
GHRS
Gh Research Plc
Recent Activity
Increased 3.43%
23.92%
$151.332M
10.763M shares@ $14.06 avg price
CGEM
Cullinan Therapeutics Inc
Recent Activity
20.14%
$127.371M
8.963M shares@ $14.21 avg price
AGIO
Agios Pharmaceuticals Inc
Recent Activity
Increased 3179.88%
13.97%
$88.349M
2.612M shares@ $33.83 avg price
DNLI
Denali Therapeutics Inc
Recent Activity
Increased 8.15%
5.71%
$36.102M
1.88M shares@ $19.21 avg price
CCCC
C4 Therapeutics Inc
Recent Activity
Decreased -1.39%
2.91%
$18.407M
6.999M shares@ $2.63 avg price
KRRO
Korro Bio Inc
Recent Activity
Increased 126.92%
2.76%
$17.414M
1.538M shares@ $11.33 avg price
TCRX
Tscan Therapeutics Inc
Recent Activity
1.29%
$8.099M
8.019M shares@ $1.01 avg price
XNCR
Xencor Inc
Recent Activity
Decreased -23.97%
1.03%
$6.469M
536,398 shares@ $12.07 avg price
DTIL
Precision Biosciences Inc
Recent Activity
Decreased -0.88%
0.86%
$5.418M
985,113 shares@ $5.51 avg price

1-10 of 23